Strides Arcolab posts Q3 net of Rs 97.39 crore

Standalone total income of the company stood at Rs 241.78 crore for the quarter under consideration

Strides-Arcolab
Press Trust of India New Delhi
Last Updated : Feb 02 2015 | 6:25 PM IST
Drug firm Strides Arcolab today reported a standalone net profit of Rs 97.39 crore for the third quarter ended December 31, 2014.

The company had posted a net profit of Rs 3,525.24 crore for the corresponding period of the previous fiscal, Strides Arcolab said in a filing to BSE.

In December 2013, the company had completed sale of its Agila Specialties Division to Mylan Inc for a total consideration of $1.75 billion.

Also Read

Standalone total income of the company stood at Rs 241.78 crore for the quarter under consideration. It was Rs 253.37 crore for the same period a year ago.

The company had a net gain of Rs 96.40 crore for the quarter ended December 31, 2014 on sale of long term investments, while it was Rs 3,265.52 crore in the quarter ended December 31, 2013, Strides Arcolab said.

Dividend income from non current investment in wholly owned subsidiaries which was nil for the third quarter of this fiscal stood at Rs 1,353.40 crore for the same period year ago, it added.

Shares of Strides Arcolab today closed at Rs 932.95 per scrip on BSE, up 0.09 per cent from their previous close.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Feb 02 2015 | 5:20 PM IST

Next Story